Jazz Pharmaceuticals (JAZZ) PT Raised to $209 at Baird
Tweet Send to a Friend
Baird analyst Joel Beatty raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $209.00 (from $160.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
